Immtech
International Inc. About
Immtech International Inc: Immtech International Inc.
is a pharmaceutical company focused on commercializing a new class of oral drugs
to treat infectious diseases. Immtech is developing oral drugs to treat
infectious diseases such as pneumonia, fungal infections ($4 billion annual sales),
malaria (affecting 2 billion people and causing 2 million deaths annually), tuberculosis
(affecting 2 billion people and causing 2 million deaths annually), diabetes (affecting
170 million people), hepatitis ($2 billion annual sales); and tropical diseases
such as African sleeping sickness (affecting 60 million people), and Leishmania
(prevalent in 80 countries).